Distinct anti-MDA5 antibody trajectories associated with long-term outcomes in 6-month survivors of anti-MDA5 dermatomyositis with interstitial lung disease
Two distinct trajectories of anti-MDA5 antibody levels among 6-month survivors with anti-MDA5 + DM-ILD have been identified. The long-term outcomes were favorable for those with fast seroconvertors.
Authors
- Zhiwei Chen (ORCID: https://orcid.org/0000-0003-3378-174X)
- Liangjing Lu
- Yakai Fu
- Kaiwen Wang
- Danting Zhang
- Xiaodong Wang
- Huijing Wang
- Wenwen Xu
- Shuang Ye
- Wanlong Wu
Institutions
- Shanghai Jiao Tong University (CN)
- Renji Hospital (CN)
Publication Details
- Journal
- Respiratory Research
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1186/s12931-026-03572-y
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00